The emerging role of clozapine in the treatment of movement disorders.
about
Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmissionA 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey modelPossible tardive dystonia resulting from clozapine therapyWorsening of motor features of parkinsonism with olanzapineTardive dyskinesia: therapeutic options for an increasingly common disorder.Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial.A review of the assessment of dyskinesias.The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.Pharmacological treatment of Parkinson's disease.Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction.The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.Atypical antipsychotics in Parkinson-sensitive populations.Tremor--easily seen but difficult to describe and treat.Psychosis in Parkinson's disease.Benefits and risks of pharmacological and surgical treatments for essential tremor: disease mechanisms and current management.Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins.Treatment of neurolept-induced tardive dyskinesiaWhere to position clozapine: re-examining the evidence.New thoughts on thought disorders in Parkinson's disease: review of current research strategies and challenges.The serotonergic system in motor and non-motor manifestations of Parkinson's disease.
P2860
Q23913269-E077D5CF-55BF-4ED6-B754-DEF0AC8796ECQ24646533-2523DA75-4082-426A-93B7-1C2A0CE499BAQ28373133-00024C69-F107-488F-A651-A62B4064E7CAQ28377314-1F51041B-0F99-43FA-A426-6B635708C927Q30566749-6889762B-6D8C-465D-86FF-9CCF9325D2DBQ32052243-1A16E150-5E24-4A07-9231-14E419E95603Q33737401-A8B1BBF9-DA0D-44AA-991E-F7F0682299FFQ33845251-FE32BB7D-FA09-47F0-AD7A-4143B11842FCQ33884378-C62FD335-AF08-4E67-B3AA-03E427F95011Q34048261-9CB512C4-4636-4569-8D3B-9DADE335223DQ34651191-DFEBFA66-F7B6-4270-AF3E-EA095B6F6F92Q34811957-615B2335-9033-423F-97BA-D0426ABB84B1Q34851726-0C2FC1C9-DF89-4E4C-B0C9-F9ABDBC69561Q35105756-FEB6C28A-DB11-4A86-BE36-5A3061245955Q35863404-D6FF5E87-53D5-4966-92BE-BB91BF1BBFFFQ36235520-F416A43C-04CE-4F76-ABC5-669A48BE76DBQ36346334-803EEA79-4FC2-460B-B298-9853F2632657Q37021326-55138633-708D-420B-953B-51BE6D1EB661Q37198420-A4679607-0C9F-432A-B686-731383E10DDAQ37801988-66C62608-D8BA-40ED-83EB-AC2C92E035ADQ37853032-B1778390-BC57-4AC8-B0F2-155B43CF24B8Q38118061-61FBFEEA-1B08-4956-8B75-8C8E0C567C4D
P2860
The emerging role of clozapine in the treatment of movement disorders.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The emerging role of clozapine in the treatment of movement disorders.
@ast
The emerging role of clozapine in the treatment of movement disorders.
@en
The emerging role of clozapine in the treatment of movement disorders.
@nl
type
label
The emerging role of clozapine in the treatment of movement disorders.
@ast
The emerging role of clozapine in the treatment of movement disorders.
@en
The emerging role of clozapine in the treatment of movement disorders.
@nl
altLabel
The emergin role of clozapine in the treatment of movement disorders
@en
prefLabel
The emerging role of clozapine in the treatment of movement disorders.
@ast
The emerging role of clozapine in the treatment of movement disorders.
@en
The emerging role of clozapine in the treatment of movement disorders.
@nl
P2860
P356
P1433
P1476
The emerging role of clozapine in the treatment of movement disorders.
@en
P2860
P304
P356
10.1002/MDS.870120403
P4011
2afba47edbefaf51a1500f742dd3e9df0df2bed5
P407
P577
1997-07-01T00:00:00Z